Nalaganje...
Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
BACKGROUND: Vonoprazan is a novel potassium‐competitive acid blocker which may provide clinical benefit in acid‐related disorders. AIM: To verify the non‐inferiority of vonoprazan vs. lansoprazole in patients with erosive oesophagitis (EE), and to establish its long‐term safety and efficacy as maint...
Shranjeno v:
| izdano v: | Aliment Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4738414/ https://ncbi.nlm.nih.gov/pubmed/26559637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.13461 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|